Bristol Myers Squibb Co stock is traded at $60.89, with a volume of 7,017,964. It is down -3.24% in the last 24 hours and up +1.91% over the past month. Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Previous Close:
$62.93
Open:
$62.13
24h Volume:
7,017,964
Relative Volume:
0.75
Market Cap:
$124.46B
Revenue:
$48.48B
Net Income/Loss:
$7.27B
P/E Ratio:
17.09
EPS:
$3.56
Net Cash Flow:
$11.91B
1W Performance:
-3.04%
1M Performance:
+1.91%
6M Performance:
+6.82%
1Y Performance:
+30.08%
1-Day Range:
$60.80$62.14
1-Week Range:
$60.80$64.94
52-Week Range:
$45.27$68.64
Bristol Myers Squibb Co Stock (BMY) Company Profile
Name
Bristol Myers Squibb CoSector
HealthcareIndustry
Drug Manufacturers - GeneralPhone
(609) 252-4621Address
ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NY, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS